Deep learning-based artificial intelligence applications in prostate MRI: brief summary.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
01 Mar 2022
Historique:
pubmed: 4 12 2021
medline: 26 2 2022
entrez: 3 12 2021
Statut: ppublish

Résumé

Prostate cancer (PCa) is the most common cancer type in males in the Western World. MRI has an established role in diagnosis of PCa through guiding biopsies. Due to multistep complex nature of the MRI-guided PCa diagnosis pathway, diagnostic performance has a big variation. Developing artificial intelligence (AI) models using machine learning, particularly deep learning, has an expanding role in radiology. Specifically, for prostate MRI, several AI approaches have been defined in the literature for prostate segmentation, lesion detection and classification with the aim of improving diagnostic performance and interobserver agreement. In this review article, we summarize the use of radiology applications of AI in prostate MRI.

Identifiants

pubmed: 34860562
doi: 10.1259/bjr.20210563
pmc: PMC8978238
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20210563

Références

Eur Radiol. 2020 Dec;30(12):6877-6887
pubmed: 32607629
Eur J Radiol. 2021 Apr;137:109600
pubmed: 33610853
N Engl J Med. 2020 Mar 5;382(10):917-928
pubmed: 32130814
J Urol. 2017 Sep;198(3):583-590
pubmed: 28373133
Invest Radiol. 2021 Oct 1;56(10):605-613
pubmed: 33787537
Cancers (Basel). 2020 May 11;12(5):
pubmed: 32403240
JAMA Oncol. 2021 Apr 1;7(4):534-542
pubmed: 33538782
JAMA. 2015 Jan 27;313(4):390-7
pubmed: 25626035
Sci Rep. 2019 Dec 20;9(1):19518
pubmed: 31863034
AJNR Am J Neuroradiol. 2018 Oct;39(10):1776-1784
pubmed: 29419402
Diagn Interv Radiol. 2019 Nov;25(6):421-427
pubmed: 31650967
Radiology. 2016 Sep;280(3):793-804
pubmed: 27035179
Abdom Radiol (NY). 2019 Jun;44(6):2030-2039
pubmed: 30460529
Eur Radiol. 2018 Jan;28(1):17-23
pubmed: 28687912
Eur Urol Oncol. 2020 Apr;3(2):145-167
pubmed: 32192942
Radiology. 2020 Jul;296(1):76-84
pubmed: 32315265
Eur Radiol. 2021 Jun;31(6):3797-3804
pubmed: 33856519
Eur Radiol. 2020 Dec;30(12):6582-6592
pubmed: 32594208
Acad Radiol. 2022 Jan;29(1):4-14
pubmed: 33162316
Abdom Radiol (NY). 2020 Dec;45(12):4252-4259
pubmed: 32211948
Acad Radiol. 2021 Feb;28(2):199-207
pubmed: 32143993
J Magn Reson Imaging. 2020 Nov;52(5):1499-1507
pubmed: 32478955
Diagn Interv Radiol. 2014 May-Jun;20(3):229-33
pubmed: 24675166
Eur Radiol. 2022 Feb;32(2):879-889
pubmed: 34327583
AJR Am J Roentgenol. 2021 Jan;216(1):111-116
pubmed: 32812797
Clin Radiol. 2010 Jun;65(6):460-4
pubmed: 20451013
Eur Radiol. 2021 Dec;31(12):9567-9578
pubmed: 33991226
Acad Radiol. 2018 Feb;25(2):188-195
pubmed: 29107458
AJR Am J Roentgenol. 2020 Dec;215(6):1403-1410
pubmed: 33052737
Eur Urol. 2019 Sep;76(3):340-351
pubmed: 30898406
J Magn Reson Imaging. 2019 Jun;49(6):1694-1703
pubmed: 30575184
Diagnostics (Basel). 2021 May 26;11(6):
pubmed: 34073627
Eur Radiol. 2021 Jun;31(6):4386-4389
pubmed: 33241520
Can Assoc Radiol J. 2021 Aug;72(3):337-338
pubmed: 32693623
Eur Urol Oncol. 2020 Oct;3(5):615-619
pubmed: 32646850
Abdom Imaging. 2015 Aug;40(6):1788-99
pubmed: 25596716
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Radiology. 2019 Dec;293(3):607-617
pubmed: 31592731
Med Phys. 2019 Apr;46(4):1707-1718
pubmed: 30702759
Med Image Anal. 2021 Oct;73:102155
pubmed: 34245943
J Med Imaging (Bellingham). 2021 Jan;8(1):010901
pubmed: 33426151
J Am Med Inform Assoc. 2021 Jun 12;28(6):1259-1264
pubmed: 33537772
Radiol Imaging Cancer. 2021 May;3(3):e200024
pubmed: 33929265
BJU Int. 2018 Sep;122(3):411-417
pubmed: 29772101
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
Diagn Interv Radiol. 2019 May;25(3):183-188
pubmed: 31063138

Auteurs

Baris Turkbey (B)

Molecular Imaging Branch, NCI, NIH, Bethesda, MD, USA.

Masoom A Haider (MA)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontorio, Canada.
Joint Department of Medical Imaging, University Health Network, Sinai Health System and University of Toronto, Toronto, Ontorio, Canada.
Ontario Institute for Cancer Research, Toronto, Ontorio, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH